Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials
Background: The association between N-acetylcysteine (NAC) and COVID-19 remains undetermined; therefore, this meta-analysis assessed the clinical efficacy of NAC in the treatment of patients with COVID-19. Methods: This study searched PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov for...
Main Authors: | Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Wan-Hsuan Hsu, Min-Hsiang Chuang, Hung-Jen Tang, Chih-Cheng Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024012106 |
Similar Items
-
The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
by: Javed Akhter, et al.
Published: (2021-03-01) -
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions
by: José Luis Izquierdo-Alonso, et al.
Published: (2022-12-01) -
Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
by: Ting-Hui Liu, et al.
Published: (2023-12-01) -
N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study
by: Siamak Afaghi, et al.
Published: (2023-05-01) -
N-acetylcysteine as an adjunct treatment of schizophrenia
by: R. Mota Freitas, et al.
Published: (2021-04-01)